2012 – Q3

2012 News Releases – Quarter 3

  • 8/3/2012
    BIOHEART RENEGOTIATES COMPANY NOTE WITH FAVORABLE TERMS
    Bioheart, Inc. (BHRT.OB) has renegotiated the terms of a Company note in the amount of $572,000 held by NorthStar Biotech, LLC, a consortium of Bioheart Directors and Shareholders, led by Bioheart Director Chuck Hart.

  • 8/2/2012
    BIOHEART RECEIVES $ 2 MILLION TERM SHEET
    INVESTMENT OFFER FROM GRUPO VITALMEX, A GLOBAL
    LEADER IN HEALTHCARE IN LATIN AMERICA AND EUROPE

    Bioheart, Inc. (BHRT.OB) announced today it has received a non-binding term sheet and investment offer in the amount of $ 2 million from Grupo Vitalmex in Mexico, a global leader in the healthcare sector in Latin America and
    Europe (www.vitalmex.com.mx).

  • 2015

    2014

    2013

    2012

    1900